Skip to main content

Table 2 Socio-demographic and disease-specific characteristics of prostate cancer survivors at the beginning of the cancer rehabilitation program with regard to work status at 12-months follow-up (N = 711)

From: Return to work in prostate cancer survivors – findings from a prospective study on occupational reintegration following a cancer rehabilitation program

  Not returned to work 12 months after the end of the rehabilitation program Returned to work 12 months after the end of the rehabilitation program  
N = 93 N = 618  
n % M SD n % M SD p-value
Socio-demographic characteristics
Age 93   59.7 3.2 618   56.9 4.4 <.001 a
Family status
 Married 77 83.7    514 83.8    .970b
 Other 15 16.3    99 16.2   
Educational level
 Up to 9 years 45 50.6    279 46.3    .442b
 10 years 22 24.7    134 22.3   
 12–13 years 22 24.7    189 31.4   
Occupational status
 Blue -collar job 34 37.4    213 34.8    .369b
 White -collar job 40 44.0    312 51.0   
 Self-employed or public servant 17 18.7    87 14.2   
Monthly household net income
 <  2000 € 24 27.9    95 16.0    .024 b
 2000- < 4000 € 48 55.8    376 63.4   
 4000 € or more 14 16.3    122 20.6   
Disease-specific characteristics
Surgical procedure
 Open (retropubic or perineal) 48 51.6    321 51.9    .953b
 Laparoscopic or robot-assisted (DaVinci) 45 48.4    297 48.1   
UICC tumor stagec          
 Stage I or II 61 65.6    501 81.2    .001 b
 Stage III 32 34.4    116 18.8   
Time since diagnosis (via punch biopsy) in months 93   3.0 6.6 618   2.8 4.7 .665a
Karnofsky performance status (0–100%) 93   78.5 7.7 618   79.3 8.8 .412a
Extent of urinary incontinence
 °0- no leakage 7 7.5    90 14.6    .179b
 °1- only in the afternoon 21 22.6    158 25.6   
 °2- already before noon 23 24.7    140 22.7   
 °3- also at night 42 45.2    228 37.0   
Number of comorbid conditions
 None 27 29.0    252 40.8    .053b
 1 35 37.6    219 35.4   
 2 or more 31 33.3    147 23.8   
Setting of the cancer rehabilitation program
 Inpatient 82 88.2    535 86.6    .671b
 Outpatient 11 11.8    83 13.4   
  1. Abbreviations M mean, SD Standard deviation, p-value, probability of type I error
  2. Significant p-values are marked in bold
  3. at-test, two-tailed
  4. bchi-square-test
  5. cUICC International Union against Cancer
\